Lisata Therapeutics Inc. (LSTA) — Cash Flow Quality Index

Latest as of June 2020: 0.68x

Lisata Therapeutics Inc. (LSTA) has a Cash Flow Quality Index of 0.68x as of June 2020. Operating cash flow of $4.50 Million is below net income of $6.60 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore LSTA operating cash flow to assess how effectively this company generates cash.

Cash Flow Quality Index

0.68x
Operating CF / Net Income

Operating Cash Flow

$4.50 Million
USD

Net Income

$6.60 Million
USD

Data as of

Jun 2020
Most recent filing

Lisata Therapeutics Inc. Cash Flow Quality Index (1995–1995)

Historical Cash Flow Quality Index for Lisata Therapeutics Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Lisata Therapeutics Inc. (LSTA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Lisata Therapeutics Inc. (1995–1995)

Year-by-year earnings quality comparison for Lisata Therapeutics Inc.. For live market cap and the full company financial profile, see market cap of Lisata Therapeutics Inc..

Year Quality Index Operating CF (USD) Net Income YoY Change
1995 -275.62x $-838.44K $3.04K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.